Clinical Trial Update: AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial update for AMR PH GL 2007 CL001 in small cell lung cancer after failure of first-line chemotherapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• AMR PH GL 2007 CL001

Snippet

Sponsor: Celgene | Conditions: Small Cell Lung Cancer | Phase 3 | Status: COMPLETED